Guardant Health (GH) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.48. This compares to a loss of $0.45 per share a year ago. These figures are ...

But climate change is disrupting this circular process. The build-up of greenhouse gases in the atmosphere has raised ...

The research is another sign that climate heating caused mainly by fossil fuel pollution is pushing the climate toward ...

List today: Gyre Therapeutics, Inc. GYRE is a biotechnology company which is focused on organ fibrosis and inflammatory diseases. The Zacks Consensus Estimate for its current year earnings has been ...

SAN DIEGO - Gyre Therapeutics (NASDAQ:GYRE), currently valued at $762 million, announced Tuesday it will present results from its Phase 3 clinical trial of Hydronidone for liver fibrosis in chronic ...

SAN DIEGO, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across ...

After nine consecutive years with at least one major hurricane landfall on the Gulf Coast, in 2025, we’ve told tropical cyclones to leave us alone and they have. There has been just one weak tropical ...

Five times stronger than the Gulf Stream and 100 times larger than the Amazon River, the Antarctic Circumpolar Current (ACC) is by far the world's largest ocean current. But this key system is ...

The former VP had a mic-drop moment when stopping by the A Day of Unreasonable Conversation summit in Los Angeles on Monday. By Kirsten Chuba Events Editor Stars across Hollywood, sports, politics and ...

The North Atlantic Subpolar Gyre moves heat from the tropics to the North Atlantic, and it is a part of a much larger network ...

Donald Trump's presidential approval rating has dropped to the lowest it's been in his second term. Here's what the president's current poll numbers show amid the government shutdown. In a contentious ...